top of page

BeverMedikalBilişim Grubu

Public·21 members

The Future — "Liquid Biopsy" vs. EMB

By 2026, a significant debate exists regarding Donor-Derived Cell-Free DNA (ddcfDNA). This blood test can detect "dying" heart cells from a transplanted organ.

  • The 2026 Consensus: If the "liquid biopsy" is negative, an invasive EMB might be skipped. However, if the blood test is positive, an EMB is still required to determine the type of rejection and the appropriate treatment. EMB is currently viewed as the "confirmatory tool" rather than the "screening tool."

20 Views

The article explains how liquid biopsies may help doctors monitor transplanted hearts and decide when further testing is needed. While preparing a university assignment, I wanted to understand medical research better and came across Economics Dissertation help UK while exploring academic resources. I found it interesting that a blood test could help reduce unnecessary invasive procedures. However, careful diagnosis remains essential because doctors still need detailed information to choose the right treatment. your forum makes me smile

Bewerkt
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • TikTok

NA KONTAKTONI

We'd love to hear from you

Kontakt

Bağlarbaşı Mahallesi Sümbül Sokak No:1/A/1 Maltepe İstanbul Türkiye
+905422307610 

Çalışma Saatlerimiz

Hafta İçi 09/19  Saatleri Arası

Hafta Sonu 10/18 Saatleri Arası

 

Nuk e gjetët produktin që po kërkoni?
Ne duam t'ju ndihmojmë

Gönderdiğiniz için teşekkür ederiz!

bottom of page